Differential therapeutic strategies for patients with social phobia;Differentielle Therapiestrategien bei Sozialer Phobie

Nervenheilkunde

Volumn 17, Issue 3, 1998, Pages 127-134

  Boerner, R J ^a   Moller H J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Behaviour therapy; Comorbidity; Moclobemide; Pharmacotherapy; Social phobia

Indexed keywords

ALPRAZOLAM; ATENOLOL; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROFAROMINE; BUSPIRONE; CLONAZEPAM; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHENELZINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NEUROSIS; PHOBIA; PRACTICE GUIDELINE; PSYCHOANALYSIS; PSYCHOPHARMACOTHERAPY; REVIEW; SOCIAL PHOBIA;

EID: 0031873675     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Agras SW, Silvester D, Oliveau D. The epidemiology of common fears and phobias. Comprehensive Psychiatry 1969; 10: 439-47.
2. Bassler N. Analytische Psychotherapie und Psychodynamik von sozialen Ängsten. In: Buchheim P (Hrsg.) Psychotherapie und Psychopharmaka. Schattauer Verlag Stuttgart 1997; 93-101.
3. Boerner RJ, Möller HJ. Pharmakotherapie der Sozialen Phobie. Nervenheilkunde 1996; 15: 459-63.
4. Boerner RJ, Möller HJ. Depression and anxiety disorders - epidemiology, theoretical concepts and therapy potentials in cases of comorbidity. International Journal of Psychiatry in Clinical Practice 1997, accepted.
5. Butler G, Cullington A, Munby M et al. Exposure and anxiety management in the treatment of social phobia. J Consult Clin Psychol 1984; 52: 642-50.
6. Clark DB, Agras WS. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 1991; 148: 598-605.
7. Davidson JRT, Ford SM, Smith RD et al. Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 1991; 52: 11: 16-20.
8. Den Boer JA, van Vliet IM, Westenberg HGM. Recent developments in the psychopharmacology of social phobia. Eur Arch Psychiatry Clin Neurosci 1995; 224: 309-16.
9. Emmelkamp PMG, Mersch PPA, Vissia E, van der Helm M. Social phobia: A comparative evaluation of cognitive and behavioural interventions. Behaviour Research and Therapy 1985; 23: 365-9.
10. Falloon IR, Lloyd GG, Harpin RE. The treatment of social phobia: real-life rehearsal with nonprofessional therapists. J Nerv Ment Dis 1981; 169: 180-4.
11. Gelernter CS, Uhde TW, Cimbolic P et al. Cognitive-behavioral and pharmacological treatment of social phobia. Arch Gen Psychiatry 1991; 48: 938-45.
12. Heimberg RG, Dodge CS, Hope DA et al. Cognitive behavioral treatment for social phobia: comparison to a credible placebo control. Cognitive Therapy and Research 1990, 14: 1-23.
13. Heimberg RG, Salzman DG, Holt CS et al. Cognitive-behavioral group treatment for social phobia: effectiveness at five-year follow-up. Cognitive Therapy and Research 1993; 17: 325-39.
14. Heimberg RE, Liebowitz MR, Hope DA, Schneier FS. Social phobia. Diagnosis, assessment, and treatment. The Guildford Press, New York, London 1996.
15. Judd LL. Social Phobia: A Clinical Overview. J Clin Psychiatry 1994; 55: 6: 5-9.
16. Katzelnick DJ, Kobak KA, Greist JH et al. Sertraline in social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995; 152: 1368-71.
17. Kessler RC, McGonagle KH, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51: 8-19.
18. Liebowitz MR, Gorman JM, Fyer Aj et al. Social phobia. Arch Gen Psychiatry 1985; 42: 729-36.
19. Mattick RP, Peters L. Treatment of severe social phobia: effects of guided exposure with and without cognitive restructuring. J Consult Clin Psychol 1988; 56: 251-60.
20. Mattick RP, Peters L, Clarke JC. Exposure and cognitive restructuring for severe social phobia. Behavior Therapy 1989; 20: 3-23.
21. Mersch PPA, Emmelkamp PMG, Lips C. Social phobia: individual response patterns and the long-term effects of behavioral and cognitive interventions. A follow-up study. Behav Res Ther 1991; 29: 357-62.
22. Newman MG, Hofmann SG, Trabert W et al. Does behavioral treatment of social phobia lead to cognitive changes? Behavior Therapy 1994; 25: 503-17.
23. Nutt D, Montgomery SA. Moclobemide in the treatment of social phobia. International Clin Psychopharmacol 1996; 11: 3: 77-82.
24. Schneier FR, Johnson J, Hornig CD et al. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992; 49: 282-7.
25. Scholing A, Emmelkamp PMG. Cognitive and behavioral treatment of fear of blushing, sweating or trembling. Behav Res Ther 1993a; 31: 155-70.
26. Scholing A, Emmelkamp PMG. Exposure with and without cognitive therapy for generalized social phobia: effects of individual and group treatment. Behav Res Ther 1993b; 31: 667-81.
27. Stravynski A, Marks I, Yule W. Social skill problems in neurotic outpatients: social skills training with and without cognitive modification. Arch Gen Psychiatry 1982; 39: 1378-85.
28. rdACNP, Puerto Rico, 1994.
29. The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia: A double-blind, placebo-controlled clinical study. Eur Arch Psychiatry Clin Neurosci 1997; 247: 71-80.
30. Turner SM, Beidel DC, Dancu CV et al. Psychopathology of social phobia and comparison to avoidant personality disorder. J Abnorm Psychol 1986; 95: 389-94.
31. Turner SM, Beidel DC, Townsley RM. Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder. J Abnorm Psychol 1992; 101: 326-31.
32. Turner SM, Beidel DC, Cooley MR et al. A multicomponent behavioral treatment for social phobia: social effectiveness therapy. Behav Res Ther 1994; 32: 381-90.
33. Turner SM, Beidel DC, Cooley-Quille MR. Two-year follow-up of social phobies treated with social effectiveness therapy. Behav Res Ther 1995; 33: 553-5.
34. Van Vliet IM, denBoer JA, Westenberg HGM. Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, selective MAO inhibitors. Eur. Neuropharmacol. II 1992; 21-9.
35. Versiani M, Nardi AE, Mundin FD et al. Pharmacotherapy in social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1992; 161: 353-60.
36. Versiani M, Nardi AE, Mundin FD et al. The long-term treatment of social phobia with moclobemide. International Clin Psychopharmacol 1996; 11: 3: 83-8.
37. Wlazlo Z, Schroeder-Hartwig K, Hand I et al. Exposure in vivo vs social skills training for social phobia: long-term outcome and differential effects. Behav Res Ther 1990; 28: 181-93.